POSTMENOPAUSAL WOMEN
Clinical trials for POSTMENOPAUSAL WOMEN explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL WOMEN trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL WOMEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Needles and current: can electroacupuncture tame menopausal weight gain and liver fat?
Disease control Not yet recruitingThis study aims to see if a 12-week course of electroacupuncture can help reduce central obesity (belly fat) and improve fatty liver in postmenopausal women. It will involve 60 women aged 50-60 who are overweight and have signs of fatty liver and high cholesterol. Researchers wil…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Robot or human? the new battle for menopause relief
Symptom relief Not yet recruitingThis study is testing whether a smartphone app using artificial intelligence (AI) can help reduce chronic pain and improve quality of life for women after menopause. It will compare the AI program to traditional sessions with a physiotherapist and to a group receiving no special …
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Baskent University • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
New hope for postmenopausal women with bladder leaks
Symptom relief Not yet recruitingThis study aims to find out if a combination of pelvic floor muscle exercises and an estrogen cream works better than the cream alone for treating stress urinary incontinence in women after menopause. About 115 participants will be randomly assigned to receive either the combined…
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: NA • Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
New injection tested against established drug in early safety trial
Knowledge-focused Not yet recruitingThis early-stage study aims to understand the safety and how long a new injection called BL0175 stays in the blood of healthy postmenopausal women. Researchers will compare it to an existing drug called fulvestrant. The trial will enroll 27 participants who will receive one dose …
Matched conditions: POSTMENOPAUSAL WOMEN
Phase: PHASE1 • Sponsor: Shanghai Best-Link Bioscience, LLC • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC